Hepatitis Monthly
Official Journal of Research Center for Gastroenterology and Liver Diseases
The Effectiveness of Nucleoside Analogues in Chronic Hepatitis B Patients Unresponsive to Interferon Therapy: Our Clinical Trials for One Year
Abstract
Copyright
© 2010, Author(s). This open-access article is available under the Creative Commons Attribution 4.0 (CC BY 4.0) International License (https://creativecommons.org/licenses/by/4.0/), which allows for unrestricted use, distribution, and reproduction in any medium, provided that the original work is properly cited.
Similar Articles
The Efficacy of Add-on Telbivudine Versus Switching to Pegylated Interferon Alfa-2a in Chronic Hepatitis B Patients With Poor Responses to Adefovir
Wei X, Fan C, Zhou Y, Kang W, Wang J, et al. The Efficacy of Add-on Telbivudine Versus Switching to Pegylated Interferon Alfa-2a in Chronic Hepatitis B Patients With Poor Responses to Adefovir. Hepat Mon. 2016;16(1):e31278. doi: https://doi.org/10.5812/hepatmon.31278
Efficacy of PEGylated Interferon in Treatment-Experienced Chinese Patients With HBeAg Positive Chronic Hepatitis B
Xiong Y, Li H, Liu F, Zhang D, Ren H, et al. Efficacy of PEGylated Interferon in Treatment-Experienced Chinese Patients With HBeAg Positive Chronic Hepatitis B. Hepat Mon. 2016;16(4):e35357. doi: https://doi.org/10.5812/hepatmon.35357
Efficacy Analysis and Influencing Factors of HBsAg Response in Chronic Hepatitis B Patients Treated with Nucleoside Analogues and Pegylated Interferon Sequential Therapy with High HBsAg Levels
Chen J, Lai S, Zheng M. Efficacy Analysis and Influencing Factors of HBsAg Response in Chronic Hepatitis B Patients Treated with Nucleoside Analogues and Pegylated Interferon Sequential Therapy with High HBsAg Levels. Hepat Mon. 2025;25(1):e165180. doi: https://doi.org/10.5812/hepatmon-165180
Recent Advances in the Management of Chronic Hepatitis B
Kim SR, Yang J, Kudo M, Hino O. Recent Advances in the Management of Chronic Hepatitis B. Hepat Mon. 2011;11(8):. doi: https://doi.org/10.5812/kowsar.1735143X.657
Hepatitis B Virus DNA Level as Predictor of Response to Therapy with Interferon-alpha-2b (PDferon) in Chronic Hepatitis B Infection
Alavian SM, Miri SM, Behzadnia MJ. Hepatitis B Virus DNA Level as Predictor of Response to Therapy with Interferon-alpha-2b (PDferon) in Chronic Hepatitis B Infection. Arch Clin Infect Dis. 2011;6(1):. doi:
- Scopus by DOI: 0
Last Update: 1 week ago
- Scopus by Title: 5
Last Update: 1 week ago
- Scopus by Title (Ref): 5
Last Update: 1 week ago
- CrossRef: 0
Last Update: 2 days ago
Ordering Reprints
Articles are published under the Creative Commons license stated on each article. No permission or royalty fee is required for uses permitted by that license. CCC handles optional bulk and customized reprint orders. Any quotation covers production and delivery services only, not copyright permission. > Request Reprints from CCC
Author(s):